This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1996 Jul;53(7):653-4.

doi: 10.1001/archpsyc.1996.01830070103016.

Venlafaxine in obsessive-compulsive disorder

J A Yaryura-Tobias, F A Neziroglu

PMID: 8660133
DOI: 10.1001/archpsyc.1996.01830070103016

Clinical Trial

Venlafaxine in obsessive-compulsive disorder

J A Yaryura-Tobias et al. Arch Gen Psychiatry. 1996 Jul.

. 1996 Jul;53(7):653-4.

doi: 10.1001/archpsyc.1996.01830070103016.

Authors

J A Yaryura-Tobias, F A Neziroglu

PMID: 8660133
DOI: 10.1001/archpsyc.1996.01830070103016

No abstract available

PubMed Disclaimer

Comment on

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Greist JH, et al. Arch Gen Psychiatry. 1995 Jan;52(1):53-60. doi: 10.1001/archpsyc.1995.03950130053006. Arch Gen Psychiatry. 1995. PMID: 7811162

Similar articles

Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
Dell'Osso B, Nestadt G, Allen A, Hollander E. Dell'Osso B, et al. J Clin Psychiatry. 2006 Apr;67(4):600-10. doi: 10.4088/jcp.v67n0411. J Clin Psychiatry. 2006. PMID: 16669725 Review.
Venlafaxine in treatment resistant obsessive-compulsive disorder.
Narayanaswamy JC, Viswanath B, Cherian AV, Math SB, Reddy YC. Narayanaswamy JC, et al. J Neuropsychiatry Clin Neurosci. 2014 Summer;26(3):E44-5. doi: 10.1176/appi.neuropsych.13080186. J Neuropsychiatry Clin Neurosci. 2014. PMID: 25093787 No abstract available.
Venlafaxine for treatment of obsessive-compulsive disorder.
Ananth J, Burgoyne K, Smith M, Swartz R. Ananth J, et al. Am J Psychiatry. 1995 Dec;152(12):1832. doi: 10.1176/ajp.152.12.1832a. Am J Psychiatry. 1995. PMID: 8526258 No abstract available.
Treatment of obsessive-compulsive disorder with venlafaxine.
Grossman R, Hollander E. Grossman R, et al. Am J Psychiatry. 1996 Apr;153(4):576-7. doi: 10.1176/ajp.153.4.576b. Am J Psychiatry. 1996. PMID: 8599411 No abstract available.
The role of venlafaxine in the treatment of obsessive-compulsive disorder.
Phelps NJ, Cates ME. Phelps NJ, et al. Ann Pharmacother. 2005 Jan;39(1):136-40. doi: 10.1345/aph.1E362. Epub 2004 Dec 7. Ann Pharmacother. 2005. PMID: 15585743 Review.

See all similar articles

Cited by

A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.
Stein DJ, Koen N, Fineberg N, Fontenelle LF, Matsunaga H, Osser D, Simpson HB. Stein DJ, et al. Curr Psychiatry Rep. 2012 Jun;14(3):211-9. doi: 10.1007/s11920-012-0268-9. Curr Psychiatry Rep. 2012. PMID: 22527872 Review.
SNRIs pharmacological alternatives for the treatment of obsessive compulsive disorder?
Sansone RA, Sansone LA. Sansone RA, et al. Innov Clin Neurosci. 2011 Jun;8(6):10-4. Innov Clin Neurosci. 2011. PMID: 21779536 Free PMC article.
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Carpenter LL, McDougle CJ, Epperson CN, Price LH. Carpenter LL, et al. Drug Saf. 1996 Aug;15(2):116-34. doi: 10.2165/00002018-199615020-00004. Drug Saf. 1996. PMID: 8884163 Review.
Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.
Pittenger C, Brennan BP, Koran L, Mathews CA, Nestadt G, Pato M, Phillips KA, Rodriguez CI, Simpson HB, Skapinakis P, Stein DJ, Storch EA. Pittenger C, et al. Psychiatry Res. 2021 Jun;300:113853. doi: 10.1016/j.psychres.2021.113853. Epub 2021 Mar 4. Psychiatry Res. 2021. PMID: 33975093 Free PMC article.
Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms.
Van Nieuwerburgh FC, Denys DA, Westenberg HG, Deforce DL. Van Nieuwerburgh FC, et al. Int J Psychiatry Clin Pract. 2009 Nov;13(1):345-348. doi: 10.3109/13651500902903016. Epub 2009 Jun 1. Int J Psychiatry Clin Pract. 2009. PMID: 20174590 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information